More than 530 associations from seven countries around the world joined together in a movement to demand that their nations’ governments suspend or block laws that would allow minors to undergo gender reassignment procedures and treatments.
The movement was created by International Feminist Front, and its objective is to ensure that "treatments with puberty blockers and cross hormones and mutilations of healthy bodies of minors who self-determine trans and reverse the laws and protocols that allow it."
The groups argue that many countries in the world have already ended protocols that allowed "gender self-determination" for children after studying the negative effects that gender-affirming treatment can have on a physical and mental level:
The latest research and the weakness of the studies on which affirmative therapy is based have led countries such as Sweden, Finland, Norway, Denmark or the United Kingdom United to change their policies regarding the use of puberty blockers. The health authorities of these countries have described hormone treatment as "experimental"; All of them have limited their use to research environments and proposed psychological support and help to address gender dysphoria/discomfort in minors and adolescents.
ACBM 19S 04 Documents Print by Veronica Silveri on Scribd
Spain joins the action
Six Spanish organizations signed a letter sent to the Spanish Ministry of Health arguing that "through transgender ideology" comes a "promotion of what sex transition is for minors." They also warn of the "threat" that this poses to "the healthy development and health of girls and boys."
The social-communist Spanish government supports these treatments for minors based on a rule called the "Trans Law," which, according to the Feminist Front, allows all surgical and pharmacological interventions to be carried out without having to consult with any mental health specialist.
The associations warn that Spanish penal code prohibits the prescription of puberty inhibitors for minors up to a certain age:
Cross-hormonalization is being prescribed to minors, which can lead, in addition to serious general health problems, to anorgasmia or painful orgasms in girls and impotence problems in boys. And healthy organs are being removed, also from minors, which contravenes article 149.2. of the Penal Code.
The letter was signed by the Alliance Against the Erasure of Women, Group of Mothers of Adolescents and Girls with Accelerated Dysphoria (AMANDA), Confluence Feminist Movement, Feminists in Congress, Feminists of Catalonia and Feminist Policy Forum. It warns of the “alarming situation” and the “health scandal that increases daily.” The groups asked “to stop these experiments on minors and adolescents, as they have already done in other countries around us.”
Pese a q el artículo 149.1 d Código Penal en vigor lo prohíbe expresamente en España se están prescribiendo tratamientos supresores d la pubertad mantenidos durante 4 o más años a niñas y niños en la fase puberal Tanner 2, lo q supondrá, en la gran mayoría d casos, esterilidad 1/ pic.twitter.com/zBdDFXeprw
— Agrupación AMANDA (@Amanda_DGIR) September 19, 2023
In the U.S., surgeries almost triple
The letter also states that these potentially harmful procedures are performed "under the calculatingly misleading term of sex or gender reassignment surgeries, a market that does not stop growing." In the U.S., this industry generated around $2.1 billion in 2022 and “is projected to grow at a compound annual growth rate (CAGR) of 11.25% between 2023 and 2030.”
The increase in the number of surgeries in the country was also observed in a recent JAMA Network Open analysis, which revealed that "the number of gender-affirming surgeries almost tripled in the United States between 2016 and 2019":
The number of interventions increased from around 4,550 in 2016 to around 13,000 in 2019. According to the analysis, around 48,000 patients underwent surgeries between 2016 and 2020.
The study shows that 85% of minors who present some type of gender dysphoria during their youth "spontaneously stop after overcoming puberty." It also argues that "there are not enough studies to support the use of puberty blockers as a treatment for dysphoria."
